BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parodi A, Kostyushev D, Brezgin S, Kostyusheva A, Borodina T, Akasov R, Frolova A, Chulanov V, Zamyatnin AA. Biomimetic approaches for targeting tumor inflammation. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Al-Hetty HRAK, Kadhim MS, Al-Tamimi JHZ, Ahmed NM, Jalil AT, Saleh MM, Kandeel M, Abbas RH. Implications of biomimetic nanocarriers in targeted drug delivery. Emergent Mater 2023;:1-13. [PMID: 36686331 DOI: 10.1007/s42247-023-00453-8] [Reference Citation Analysis]
2 Kola P, Nagesh PKB, Roy PK, Deepak K, Reis RL, Kundu SC, Mandal M. Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo- and radioresistances. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2023;:e1876. [PMID: 36600447 DOI: 10.1002/wnan.1876] [Reference Citation Analysis]
3 Lin N, Li J, Yao X, Zhang X, Liu G, Zhang Z, Weng S. Prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer liver metastasis: A meta-analysis of results from multivariate analysis. International Journal of Surgery 2022;107:106959. [DOI: 10.1016/j.ijsu.2022.106959] [Reference Citation Analysis]
4 Sukocheva OA, Zhang Y. Nanomedicines: Targeting inflammatory pathway in cancer and aging. Seminars in Cancer Biology 2022;86:1218-1221. [DOI: 10.1016/j.semcancer.2022.10.008] [Reference Citation Analysis]
5 Kutumova EO, Akberdin IR, Kiselev IN, Sharipov RN, Egorova VS, Syrocheva AO, Parodi A, Zamyatnin AA, Kolpakov FA. Physiologically Based Pharmacokinetic Modeling of Nanoparticle Biodistribution: A Review of Existing Models, Simulation Software, and Data Analysis Tools. IJMS 2022;23:12560. [DOI: 10.3390/ijms232012560] [Reference Citation Analysis]
6 Canaparo R, Foglietta F, Barbero N, Serpe L. The promising interplay between sonodynamic therapy and nanomedicine. Adv Drug Deliv Rev 2022;189:114495. [PMID: 35985374 DOI: 10.1016/j.addr.2022.114495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]